CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-18 | Flynn Sean C. VP, General Counsel | Grant or award · Stock Option (right to buy) | +2,865 | 2,865 | ||
| 2022-02-18 | Colangelo Dominick President and CEO | Grant or award · Stock Option (right to buy) | +2,865 | 2,865 | ||
| 2022-02-18 | Colangelo Dominick President and CEO | Grant or award · Stock Option (right to buy) | +270,135 | 270,135 | ||
| 2022-02-18 | Colangelo Dominick President and CEO | Grant or award · Restricted Stock Unit | +46,800 | 46,800 | ||
| 2022-02-18 | Mara Joseph Anthony Jr Chief Financial Officer | Grant or award · Restricted Stock Unit | +11,018 | 11,018 | ||
| 2022-02-18 | Mara Joseph Anthony Jr Chief Financial Officer | Grant or award · Stock Option (right to buy) | +2,865 | 2,865 | ||
| 2022-02-18 | Mara Joseph Anthony Jr Chief Financial Officer | Grant or award · Stock Option (right to buy) | +61,404 | 61,404 | ||
| 2022-02-11 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +1,625 | 45,669 | ||
| 2022-02-11 | Hopper Jonathan Mark Chief Medical Officer | Shares withheld for taxes | −775 | $35.26 | $27K | 44,894 |
| 2022-02-11 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Restricted Stock Unit | −1,625 | $35.26 | $57K | 3,250 |
| 2022-02-11 | Halpin Michael Chief Operating Officer | Option exercise | +3,500 | 10,247 | ||
| 2022-02-11 | Halpin Michael Chief Operating Officer | Shares withheld for taxes | −1,564 | $35.26 | $55K | 8,683 |
| 2022-02-11 | Halpin Michael Chief Operating Officer | Option exercise · Restricted Stock Unit | −3,500 | $35.26 | $123K | 7,000 |
| 2022-02-11 | Colangelo Dominick President and CEO | Option exercise | +7,500 | 154,621 | ||
| 2022-02-11 | Colangelo Dominick President and CEO | Shares withheld for taxes | −3,251 | $35.26 | $115K | 151,370 |
| 2022-02-11 | Colangelo Dominick President and CEO | Option exercise · Restricted Stock Unit | −7,500 | $35.26 | $264K | 15,000 |
| 2022-02-06 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +650 | 44,354 | ||
| 2022-02-06 | Hopper Jonathan Mark Chief Medical Officer | Shares withheld for taxes | −310 | $33.91 | $11K | 44,044 |
| 2022-02-06 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Restricted Stock Unit | −650 | $33.91 | $22K | 650 |
| 2022-02-06 | Halpin Michael Chief Operating Officer | Option exercise | +1,875 | 7,678 |
Page 44 of 75 · 1,497 trades